Global Immunotherapy Drugs Market Professional Survey Report 2016

Published: Jun, 2016 | Pages: 114 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report mainly covers the following

Product types including

    mAbs
    Immune checkpoint inhibitors
    Vaccines
    Non-specific immunotherapies

The segment applications including

    Hospital use
    Clinic use
    School use
    Others

Segment regions including (the separated region report can also be offered)

    North America
    Europe
    Japan
    China
    Southeast Asia
    India

The players list (Partly, Players you are interested in can also be added)

    Roche
    Merck
    Novartis
    GlaxoSmithKline (GSK)
    Amgen
    Bristol-Myers Squibb
    Eli Lilly and Company
    Celgene
    Seattle Genetics
    Spectrum Pharmaceuticals
    AbbVie Inc.
    Amgen Inc.
    Bristol-Myers Squibb Company (BMS)
    F. Hoffmann-La Roche AG
    Johnson & Johnson Private Ltd.
    Merck & Co. Inc.?
    AB Science
    AstraZeneca
    Baxter
    Bayer
    Biotech Pharmaceutical?
    Daiichi Sankyo
    Immunomedics
    Sandoz
    TG Therapeutics
    Takeda
With 26 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

 Table of Contents


1 Industry Overview of Immunotherapy Drugs
    1.1 Definition and Specifications of Immunotherapy Drugs
        1.1.1 Definition of Immunotherapy Drugs
        1.1.2 Specifications of Immunotherapy Drugs
    1.2 Classification of Immunotherapy Drugs
        1.2.1 mAbs
        1.2.2 Immune checkpoint inhibitors
        1.2.3 Vaccines
        1.2.4 Non-specific immunotherapies
    1.3 Applications of Immunotherapy Drugs
        1.3.1 Hospital use
        1.3.2 Clinic use
        1.3.3 School use
        1.3.4 Others
    1.4 Industry Chain Structure of Immunotherapy Drugs
    1.5 Industry Overview and Major Regions Status of Immunotherapy Drugs
        1.5.1 Industry Overview of Immunotherapy Drugs
        1.5.2 Global Major Regions Status of Immunotherapy Drugs
    1.6 Industry Policy Analysis of Immunotherapy Drugs
    1.7 Industry News Analysis of Immunotherapy Drugs

2 Manufacturing Cost Structure Analysis of Immunotherapy Drugs
    2.1 Raw Material Suppliers and Price Analysis of Immunotherapy Drugs
    2.2 Equipment Suppliers and Price Analysis of Immunotherapy Drugs
    2.3 Labor Cost Analysis of Immunotherapy Drugs
    2.4 Other Costs Analysis of Immunotherapy Drugs
    2.5 Manufacturing Cost Structure Analysis of Immunotherapy Drugs
    2.6 Manufacturing Process Analysis of Immunotherapy Drugs

3 Technical Data and Manufacturing Plants Analysis of Immunotherapy Drugs
    3.1 Capacity and Commercial Production Date of Global Immunotherapy Drugs Major Manufacturers in 2015
    3.2 Manufacturing Plants Distribution of Global Immunotherapy Drugs Major Manufacturers in 2015
    3.3 R&D Status and Technology Source of Global Immunotherapy Drugs Major Manufacturers in 2015
    3.4 Raw Materials Sources Analysis of Global Immunotherapy Drugs Major Manufacturers in 2015

4 Global Immunotherapy Drugs Overall Market Overview
    4.1 2011-2016E Overall Market Analysis
        4.2.1 2011-2015 Global Immunotherapy Drugs Capacity and Growth Rate Analysis
        4.2.2 2015 Immunotherapy Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2011-2015 Global Immunotherapy Drugs Sales and Growth Rate Analysis
        4.3.2 2015 Immunotherapy Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2011-2015 Global Immunotherapy Drugs Sales Price
        4.4.2 2015 Immunotherapy Drugs Sales Price Analysis (Company Segment)
    4.5 Gross Margin Analysis
        4.5.1 2011-2015 Global Immunotherapy Drugs Gross Margin
        4.5.2 2015 Immunotherapy Drugs Gross Margin Analysis (Company Segment)

5 Immunotherapy Drugs Regional Market Analysis
    5.1 North America Immunotherapy Drugs Market Analysis
        5.1.1  North America Immunotherapy Drugs  Market Overview
        5.1.2  North America 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3  North America 2011-2016E Immunotherapy Drugs Sales Price Analysis
        5.1.4  North America 2015 Immunotherapy Drugs Market Share Analysis
    5.2 Europe Immunotherapy Drugs Market Analysis
        5.2.1  Europe Immunotherapy Drugs  Market Overview
        5.2.2  Europe 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3  Europe 2011-2016E Immunotherapy Drugs Sales Price Analysis
        5.2.4  Europe 2015 Immunotherapy Drugs Market Share Analysis
    5.3 Japan Immunotherapy Drugs Market Analysis
        5.3.1  Japan Immunotherapy Drugs  Market Overview
        5.3.2  Japan 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3  Japan 2011-2016E Immunotherapy Drugs Sales Price Analysis
        5.3.4  Japan 2015 Immunotherapy Drugs Market Share Analysis
    5.4 China Immunotherapy Drugs Market Analysis
        5.4.1  China Immunotherapy Drugs  Market Overview
        5.4.2  China 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3  China 2011-2016E Immunotherapy Drugs Sales Price Analysis
        5.4.4  China 2015 Immunotherapy Drugs Market Share Analysis
    5.5 Southeast Asia Immunotherapy Drugs Market Analysis
        5.5.1  Southeast Asia Immunotherapy Drugs  Market Overview
        5.5.2  Southeast Asia 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3  Southeast Asia 2011-2016E Immunotherapy Drugs Sales Price Analysis
        5.5.4  Southeast Asia 2015 Immunotherapy Drugs Market Share Analysis
    5.6 India Immunotherapy Drugs Market Analysis
        5.6.1  India Immunotherapy Drugs  Market Overview
        5.6.2  India 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3  India 2011-2016E Immunotherapy Drugs Sales Price Analysis
        5.6.4  India 2015 Immunotherapy Drugs Market Share Analysis

6 Global 2011-2016E Immunotherapy Drugs Segment Market Analysis (by Type)
    6.1 Global 2011-2016E Immunotherapy Drugs Sales by Type
    6.2 Different Types Immunotherapy Drugs Product Interview Price Analysis
    6.3 Different Types Immunotherapy Drugs Product Driving Factors Analysis
        6.3.1 mAbs Immunotherapy Drugs Growth Driving Factor Analysis
        6.3.2 Immune checkpoint inhibitors Immunotherapy Drugs Growth Driving Factor Analysis
        6.3.3 Vaccines Immunotherapy Drugs Growth Driving Factor Analysis
        6.3.4 Non-specific immunotherapies Immunotherapy Drugs Growth Driving Factor Analysis

7 Global 2011-2016E Immunotherapy Drugs Segment Market Analysis (by Application)
    7.1 Global 2011-2016E  Consumption by Application
    7.2 Different Application  Product Interview Price Analysis
    7.3 Different Application  Product Driving Factors Analysis
        7.3.1 Hospital use Immunotherapy Drugs Growth Driving Factor Analysis
        7.3.2 Clinic use Immunotherapy Drugs Growth Driving Factor Analysis
        7.3.3 School use Immunotherapy Drugs Growth Driving Factor Analysis
        7.3.4 Others Immunotherapy Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Immunotherapy Drugs
    8.1 Roche
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
        8.1.3 Roche 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Roche 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.2 Merck
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
        8.2.3 Merck 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Merck 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.3 Novartis
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
        8.3.3 Novartis 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Novartis 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.4 GlaxoSmithKline (GSK)
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
        8.4.3 GlaxoSmithKline (GSK) 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 GlaxoSmithKline (GSK) 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.5 Amgen
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
        8.5.3 Amgen 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Amgen 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.6 Bristol-Myers Squibb
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
        8.6.3 Bristol-Myers Squibb 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Bristol-Myers Squibb 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.7 Eli Lilly and Company
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
        8.7.3 Eli Lilly and Company 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Eli Lilly and Company 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.8 Celgene
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
        8.8.3 Celgene 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Celgene 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.9 Seattle Genetics
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
        8.9.3 Seattle Genetics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Seattle Genetics 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.10 Spectrum Pharmaceuticals
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
        8.10.3 Spectrum Pharmaceuticals 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Spectrum Pharmaceuticals 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.11 AbbVie Inc.
        8.11.1 Company Profile
        8.11.2 Product Picture and Specifications
        8.11.3 AbbVie Inc. 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.11.4 AbbVie Inc. 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.12 Amgen Inc.
        8.12.1 Company Profile
        8.12.2 Product Picture and Specifications
        8.12.3 Amgen Inc. 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.12.4 Amgen Inc. 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.13 Bristol-Myers Squibb Company (BMS)
        8.13.1 Company Profile
        8.13.2 Product Picture and Specifications
        8.13.3 Bristol-Myers Squibb Company (BMS) 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.13.4 Bristol-Myers Squibb Company (BMS) 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.14 F. Hoffmann-La Roche AG
        8.14.1 Company Profile
        8.14.2 Product Picture and Specifications
        8.14.3 F. Hoffmann-La Roche AG 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.14.4 F. Hoffmann-La Roche AG 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.15 Johnson & Johnson Private Ltd.
        8.15.1 Company Profile
        8.15.2 Product Picture and Specifications
        8.15.3 Johnson & Johnson Private Ltd. 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.15.4 Johnson & Johnson Private Ltd. 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.16 Merck & Co. Inc.?
        8.16.1 Company Profile
        8.16.2 Product Picture and Specifications
        8.16.3 Merck & Co. Inc.? 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.16.4 Merck & Co. Inc.? 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.17 AB Science
        8.17.1 Company Profile
        8.17.2 Product Picture and Specifications
        8.17.3 AB Science 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.17.4 AB Science 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.18 AstraZeneca
        8.18.1 Company Profile
        8.18.2 Product Picture and Specifications
        8.18.3 AstraZeneca 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.18.4 AstraZeneca 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.19 Baxter
        8.19.1 Company Profile
        8.19.2 Product Picture and Specifications
        8.19.3 Baxter 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.19.4 Baxter 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.20 Bayer
        8.20.1 Company Profile
        8.20.2 Product Picture and Specifications
        8.20.3 Bayer 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.20.4 Bayer 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.21 Biotech Pharmaceutical?
        8.21.1 Company Profile
        8.21.2 Product Picture and Specifications
        8.21.3 Biotech Pharmaceutical? 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.21.4 Biotech Pharmaceutical? 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.22 Daiichi Sankyo
        8.22.1 Company Profile
        8.22.2 Product Picture and Specifications
        8.22.3 Daiichi Sankyo 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.22.4 Daiichi Sankyo 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.23 Immunomedics
        8.23.1 Company Profile
        8.23.2 Product Picture and Specifications
        8.23.3 Immunomedics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.23.4 Immunomedics 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.24 Sandoz
        8.24.1 Company Profile
        8.24.2 Product Picture and Specifications
        8.24.3 Sandoz 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.24.4 Sandoz 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.25 TG Therapeutics
        8.25.1 Company Profile
        8.25.2 Product Picture and Specifications
        8.25.3 TG Therapeutics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.25.4 TG Therapeutics 2015 Immunotherapy Drugs Business Region Distribution Analysis
    8.26 Takeda
        8.26.1 Company Profile
        8.26.2 Product Picture and Specifications
        8.26.3 Takeda 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.26.4 Takeda 2015 Immunotherapy Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of  Market
    9.1 Global  Market Trend Analysis
        9.1.1 Global 2016-2021  Market Size (Volume and Value) Forecast
        9.1.2 Global 2016-2021  Sales Price Forecast
        9.1.3 Global 2016-2021  Gross Margin Forecast
    9.2  Regional Market Trend
        9.2.1 North America 2016-2021 Immunotherapy Drugs Consumption Forecast
        9.2.2 Europe 2016-2021 Immunotherapy Drugs Consumption Forecast
        9.2.3 Japan 2016-2021 Immunotherapy Drugs Consumption Forecast
        9.2.4 China 2016-2021 Immunotherapy Drugs Consumption Forecast
        9.2.5 Southeast Asia 2016-2021 Immunotherapy Drugs Consumption Forecast
        9.2.6 India 2016-2021 Immunotherapy Drugs Consumption Forecast
    9.3  Market Trend (Product type)
    9.4  Market Trend (Application)

10 Immunotherapy Drugs Marketing Model Analysis
    10.1 Immunotherapy Drugs Regional Marketing Model Analysis
    10.2 Immunotherapy Drugs International Trade Model Analysis
    10.3 Traders or Distributors with Contact Information of Immunotherapy Drugs by Regions
    10.4 Immunotherapy Drugs Supply Chain Analysis

11 Consumers Analysis of Immunotherapy Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    �

12 New Project Investment Feasibility Analysis of Immunotherapy Drugs
    12.1 New Project SWOT Analysis of Immunotherapy Drugs
    12.2 New Project Investment Feasibility Analysis of Immunotherapy Drugs

13 Conclusion of the Global Immunotherapy Drugs Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.